Medicare Enrolled

Dr. Mark Koone, MD

Dermatology · Sherman, TX
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
230 E SYCAMORE ST STE 305, Sherman, TX 75090
9037714613
In practice since 2006 (20 years)
NPI: 1720055833 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Koone from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Koone? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Koone

Dr. Mark Koone is a dermatology in Sherman, TX, with 20 years in practice. Based on federal Medicare data, Dr. Koone performed 7,447 Medicare services across 3,158 unique beneficiaries.

Between the years covered by Open Payments, Dr. Koone received a total of $7,793 from 33 pharmaceutical and/or device companies across 403 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in dermatology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Koone is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice▲ Top 15% volume in TX$ $7,793 industry payments

Medicare Practice Summary

Medicare Utilization ↗
7,447
Medicare services
Top 15% in TX for dermatology
3,158
Unique beneficiaries
$32
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~372 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Destruction of precancerous skin growths, 2-144,047$5$14
Destruction of precancerous skin growth, 1936$37$136
Office visit, established patient (20-29 min)586$61$186
Destruction of skin growths (warts/lesions), 1-14353$73$236
Skin biopsy, tangential269$63$217
Office visit, established patient (10-19 min)248$38$115
Destruction of precancer skin growth, 15 or more growths239$116$343
New patient office visit (30-44 min)173$68$228
Office visit, established patient (30-39 min)77$88$253
New patient office or other outpatient visit, 15-29 minutes73$43$149
Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 0.6-1.0 cm63$121$371
Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm61$126$307
Biopsy of related skin growth, each additional growth50$38$110
Destruction of cancer skin growth of trunk, arms, or legs, 0.6-1.0 cm43$93$307
Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm39$203$639
Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 1.1-2.0 cm36$140$425
Punch biopsy, first skin growth26$95$270
Destruction of cancer skin growth of scalp, neck, hands, feet, or genitals, 1.1-2.0 cm24$131$390
New patient office visit (45-59 min)24$112$340
Destruction of cancer skin growth of scalp, neck, hands, feet, or genitals, 0.6-1.0 cm22$112$343
Removal of noncancer skin growth of body, arms, or legs, 1.1-2.0 cm18$67$358
Simple or single drainage of skin abscess14$91$254
Destruction of cancer skin growth of trunk, arms, or legs, 2.1-3.0 cm13$143$399
Biopsy of ear13$52$205
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$7,793
Total received (2018-2024)
Avg $1,113/year across 7 years
Top 35% in TX for dermatology
33
Companies
403
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$7,363 (94.5%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$431 (5.5%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,576
2023
$1,401
2022
$2,316
2021
$897
2020
$232
2019
$586
2018
$786

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$1,101
Lilly USA, LLC
$839
Janssen Biotech, Inc.
$777
Sun Pharmaceutical Industries Inc.
$762
SUN PHARMACEUTICAL INDUSTRIES INC.
$412
Regeneron Healthcare Solutions, Inc.
$395
AbbVie, Inc.
$309
Dermavant Sciences, Inc.
$299
Amgen Inc.
$292
GENZYME CORPORATION
$276
Incyte Corporation
$260
AbbVie Inc.
$253
Novartis Pharmaceuticals Corporation
$247
Ortho Dermatologics, a division of Bausch Health US, LLC
$189
PFIZER INC.
$186
LEO Pharma Inc.
$167
Galderma Laboratories, L.P.
$137
Genentech USA, Inc.
$136
Nabriva Therapeutics, plc
$99
E.R. Squibb & Sons, L.L.C.
$94
Almirall LLC
$91
Boehringer Ingelheim Pharmaceuticals, Inc.
$81
UCB, Inc.
$68
Arcutis Biotherapeutics, Inc.
$62
Celgene Corporation
$54
MAYNE PHARMA INC.
$45
Fresenius Kabi USA, LLC
$39
Kerecis Limited
$32
Helsinn Therapeutics (U.S.), Inc.
$31
ConvaTec Inc.
$20
DUSA Pharmaceuticals, Inc.
$14
Journey Medical Corporation
$14
Kyowa Kirin, Inc.
$13
Top 3 companies account for 34.9% of total payments
Associated products mentioned in payments ›
20% · ADBRY · AKLIEF · ARAZLO · Absorica LD · BIAFINE · BLU-U · Bimzelx · COSENTYX · CYLTEZO · Cimzia · DUOBRII · DUPIXENT · DUPIXENT DUPILUMAB INJECTION · EBGLYSS · EPSOLAY · EUCRISA · Erivedge · HUMIRA · Humira · IDACIO · ILUMYA · ILUMYA (tildrakizumab-asmn) injection · INNOVAMATRIX AC · Ilumya · JUBLIA · Kerecis Omega3 SurgiClose · Klisyri · LIBTAYO · Levulan Kerastick (aminolevulinic acid HCl) for Topical Solution · OPZELURA · ORACEA · Odomzo · Otezla · PICATO · Pomalyst · Poteligeo · QBREXZA · REMICADE · RINVOQ · Rituxan · SILIQ · SKYRIZI · SOOLANTRA · SPEVIGO · STELARA · Sivextro · Skyrizi · Sotyktu · TALTZ · TREMFYA · Tremfya · VALCHLOR · VTAMA · Winlevi · Zoryve
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (94%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $105 per 100 Medicare services performed
Looking for a dermatology in Sherman?
Compare dermatologys in the Sherman area by procedure volume, costs, and industry payment transparency.
Browse dermatologys nearby

Geographic Context

Dermatologys within 10 mi
9
Per 100K population
6.4
County median income
$70,455
Nearest hospital
BAYLOR SCOTT AND WHITE SURGICAL HOSPITAL AT SHERMA
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Koone is a mixed practice specialist, with above-average Medicare volume (top 15% in TX), and low-engagement industry engagement, with 20 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Koone experienced with destruction of precancerous skin growths, 2-14?
Based on Medicare claims data, Dr. Koone performed 4,047 destruction of precancerous skin growths, 2-14 services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Koone receive payments from pharmaceutical companies?
Yes. Dr. Koone received a total of $7,793 from 33 companies across 403 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Koone's costs compare to other dermatologys in Sherman?
Dr. Koone's average Medicare payment per service is $32. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Koone) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →